[go: up one dir, main page]

GT200600427A - Compuestos organicos - Google Patents

Compuestos organicos

Info

Publication number
GT200600427A
GT200600427A GT200600427A GT200600427A GT200600427A GT 200600427 A GT200600427 A GT 200600427A GT 200600427 A GT200600427 A GT 200600427A GT 200600427 A GT200600427 A GT 200600427A GT 200600427 A GT200600427 A GT 200600427A
Authority
GT
Guatemala
Prior art keywords
manufacture
invention refers
organic compounds
same
formula
Prior art date
Application number
GT200600427A
Other languages
English (en)
Inventor
Stuart John Mickel
Wolfgang Materer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35394904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT200600427(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT200600427A publication Critical patent/GT200600427A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/24Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)

Abstract

LA INVENCIÓN SE REFIERE A UN PROCESO NOVEDOSO, A PASOS DE PROCESO NOVEDOSOS, Y A INTERMEDIARIOS NOVEDOSOS ÚTILES EN LA SÍNTESIS DE COMPUESTOS FARMACÉUTICAMENTE ACTIVOS, EN ESPECIAL INHIBIDORES DE RENINA, TALES COMO ALISQUIRENO. ENTRE OTRAS COSAS, LA INVENCIÓN SE REFIERE A UN PROCESO PARA LA FABRICACIÓN DE UN COMPUESTO DE FÓRMULA III, EN DONDE R, R1 Y R´SON COMO SE DEFINEN EN LA MEMORIA DESCRIPTIVA, O UNA SAL DEL MISMO, Y UN COMPUESTO DE LA FÓRMULA IV, EN DONDE R, R1, R2 Y R´ SON COMO SE DEFINEN EN LA MEMORIA DESCRIPTIVA, Y A PROCESOS PARA LA FABRICACIÓN DE LOS MISMOS.
GT200600427A 2005-09-28 2006-09-25 Compuestos organicos GT200600427A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0519764.5A GB0519764D0 (en) 2005-09-28 2005-09-28 Organic compounds

Publications (1)

Publication Number Publication Date
GT200600427A true GT200600427A (es) 2007-04-30

Family

ID=35394904

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600427A GT200600427A (es) 2005-09-28 2006-09-25 Compuestos organicos

Country Status (27)

Country Link
US (2) US7973175B2 (es)
EP (2) EP2287153A1 (es)
JP (1) JP2009509990A (es)
KR (1) KR20080048042A (es)
CN (1) CN101273012A (es)
AR (1) AR057137A1 (es)
AT (1) ATE492533T1 (es)
AU (1) AU2006299097B2 (es)
BR (1) BRPI0616707A2 (es)
CA (1) CA2623495A1 (es)
DE (1) DE602006019114D1 (es)
EC (1) ECSP088319A (es)
ES (1) ES2358536T3 (es)
GB (1) GB0519764D0 (es)
GT (1) GT200600427A (es)
IL (1) IL189763A0 (es)
MA (1) MA29852B1 (es)
MY (1) MY143251A (es)
NO (1) NO20082005L (es)
NZ (1) NZ566429A (es)
PE (1) PE20070488A1 (es)
PL (1) PL1931629T3 (es)
PT (1) PT1931629E (es)
RU (1) RU2423348C2 (es)
TN (1) TNSN08142A1 (es)
TW (1) TW200730480A (es)
WO (1) WO2007039183A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2062874B1 (en) 2007-11-20 2014-12-17 KRKA, tovarna zdravil, d.d., Novo mesto Process and intermediates for the preparation of aliskiren
EP2189442B1 (en) 2008-11-20 2014-10-01 Krka Tovarna Zdravil, D.D., Novo Mesto Process and intermediates for the preparation of aliskiren
US8203005B2 (en) 2009-10-29 2012-06-19 Carbo Design Llc Manufacturing process for enantiomerically pure 8-aryloctanoic acids as Aliskiren
CN101774986B (zh) * 2010-01-06 2012-03-28 浙江天宇药业股份有限公司 一种制备阿利克伦及其中间体的方法
CN101863796B (zh) * 2010-05-12 2011-08-24 海南美兰史克制药有限公司 一种阿利克仑化合物及其制法
EP2551260A1 (en) 2011-07-28 2013-01-30 Chemo Ibérica, S.A. Chemical process for opening ring compounds
US8703976B2 (en) 2011-10-02 2014-04-22 Milan Soukup Manufacturing process for 8-aryloctanoic acids such as Aliskiren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421295A1 (de) 1984-06-08 1985-12-12 Basf Ag, 6700 Ludwigshafen Neue pyrrolidincarbonsaeurederivative, verfahren zu ihrer herstellung
MY119161A (en) 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
HU228526B1 (hu) 2000-07-05 2013-03-28 Speedel Pharma Ag Eljárás szubsztituált oktanoil-amid-származékok elõállítására, valamint az elõállításhoz alkalmazott közbensõ termékek
DE10116816A1 (de) 2001-04-04 2002-10-17 Basf Ag Verfahren zur Herstellung von N-Benzylaminen
GB0419361D0 (en) 2004-08-31 2004-10-06 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
AU2006299097A1 (en) 2007-04-12
ECSP088319A (es) 2008-04-28
JP2009509990A (ja) 2009-03-12
ES2358536T3 (es) 2011-05-11
AR057137A1 (es) 2007-11-21
MY143251A (en) 2011-04-15
RU2008116317A (ru) 2009-11-10
EP1931629B1 (en) 2010-12-22
GB0519764D0 (en) 2005-11-09
PE20070488A1 (es) 2007-06-13
NO20082005L (no) 2008-06-24
MA29852B1 (fr) 2008-10-03
BRPI0616707A2 (pt) 2011-06-28
CN101273012A (zh) 2008-09-24
US20110230665A1 (en) 2011-09-22
WO2007039183A1 (en) 2007-04-12
AU2006299097B2 (en) 2010-11-04
US7973175B2 (en) 2011-07-05
NZ566429A (en) 2010-10-29
EP2287153A1 (en) 2011-02-23
US20080255369A1 (en) 2008-10-16
PL1931629T3 (pl) 2011-05-31
DE602006019114D1 (de) 2011-02-03
CA2623495A1 (en) 2007-04-12
IL189763A0 (en) 2008-08-07
TW200730480A (en) 2007-08-16
PT1931629E (pt) 2011-03-09
TNSN08142A1 (en) 2009-07-14
RU2423348C2 (ru) 2011-07-10
ATE492533T1 (de) 2011-01-15
KR20080048042A (ko) 2008-05-30
EP1931629A1 (en) 2008-06-18

Similar Documents

Publication Publication Date Title
ECSP099708A (es) Nuevos métodos
ECSP088368A (es) Derivados de 3-alquil-5-(4-alquil-5-oxo-tetrahidrofuran-2-il)-pirrolidin-2-ona como intermediarios en la síntesis de inhibidores de renina
CU20090225A7 (es) 2-piperidinilo bencimidazoles útiles en el tratamiento del crecimiento celular anormal
CU20190086A7 (es) Compuestos de heteroarilo bicíclicos 6-6 fusionados útiles como inhibidores de lats
GT200700036A (es) Compuestos fenil amido heterociclicos condensados
CO6700837A2 (es) Proceso de elaboración para derivados de prrimidina
UY32096A (es) Derivados de 2-carboxamida - cicloamino - urea especìficos, sus sales farmacèuticamente aceptables, composiciones contenièndolos, pro-farmacos de los mismos, procesos para su produciòn y aplicaciones
ECSP12011799A (es) Compuestos de espiropiperidina y uso farmacéutico de los mismos
CL2009000394A1 (es) Compuestos derivados de n-(1h-indazol-5-il)pirrolidin-3-carboxamida sustituida, inhibidores de erk; composicion farmaceutica; y su uso en el tratamiento del cancer.
CR20140361A (es) Inhibidores de pde9 con estructura básica de imidazotriazinona
CO6220955A2 (es) Una composicion farmaceutica que contiene (a) n1-(5-cloropiridin-2-il)-n2-((1s,2r,4s)-4-[dimetilamino)carbonil]-2-{[(5-metil-4,5,6,7-tetrahidrotiazol[5,4-c]piridin-2-il) carbonil] amino} coclohexil)etanodiamida
DOP2011000113A (es) Pirazolilaminopiridinas como inhibidores de fak
DOP2006000170A (es) Nuevos derivados de espirocromanona
CR20120296A (es) Nuevos compuestos de espiropiperidina
AR066709A1 (es) Proceso para la produccion de pirazoles
CU20150084A7 (es) Derivados del ácido 4-((1,1) bisfenil -4-il)-3-(3-fosfonopropanamido)butanoico,activo como inhibidores de nep(endopeptidasa neutral)
ECSP088319A (es) Síntesis de inhibidores de renina que involucra una reacción de cicloadición
GT200900009A (es) Bencilaminas, un proceso para su produccion y su uso como agentes anti-inflamatorios
CU20110101A7 (es) 1-(arilsulfonil)-4-(piperazin-1-il)-1h-benzimidazoles como ligandos de 5-hidroxitriptamina-6
PE20151055A1 (es) Compuestos triciclicos para inhibir el canal cftr
ECSP077986A (es) Procedimiento para preparar inhibidores de renina
ECSP088781A (es) Derivados de benzimidazol
PE20070122A1 (es) Proceso para preparar derivados de piperazina azindoloxoacetica sustituida con triazol y nuevas formas de sal producidas de los mismos
EA201000616A1 (ru) Фунгицидные соединения, способ их получения и их применение для борьбы с вредными грибами, а также содержащие их средства
NO20080262L (no) Fremgangsmate for produksjonen av intermediater for fremstilling av tricykliske benzimidazoler